TNF and amyotrophic lateral sclerosis: This concept could possibly extend to patients with a cell death-driven autoimmune or otherwise inflammation-associated disease in which TNF inhibition, at least when applied alone, has so far failed, including amyotrophic lateral sclerosis and multiple sclerosis54,55.